FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
Back to search
Official data from USPTO
BIOCELLIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOCELLIC
ST13
US500000079414765Class
1, 3, 5, 17
Filing
79414765
Registration
8226581
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
07/28/2026
Trademark type
Word
Nice classes
1, 3, 5, 17
Filing date
10/31/2024
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
SWAIN, MICHELE LYNN
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
JeNaCell GmbH
Representatives
Joseph V. Norvell
Technical classification
Nice Classes
Class 1Class 3Class 5Class 17
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cellulose precursors and cellulose intermediates for cosmeticalpharmaceuticalmedical and veterinary-medical end products; cellulose for use as raw material for wound dressings; cellulose made by bacteria; cellulose for industrial purposes; cellulose gel; nanocellulose; unprocessed cellulose fleececellulose foilcellulose films and cellulose fibres; cellulose fibres suspensions and cellulose gels of nanocellulose; cellulose and nanocellulose productsbiosynthetic cellulose and synthetic cellulose as precursors for veterinarycosmetical productsparticularly for wound dressings; cellulose ingredients for use in the cosmetic and medical industries; cellulose and nanocellulose productsbiosynthetic cellulose and synthetic cellulose as precursors for pharmaceutical products; cellulose-based ingredients for use in manufacturing cosmetics industry and the medical device industry; cellulose-based ingredients as support materialthickening and binding agents for use in manufacturing cosmetics and medical productsparticularly wound dressings and skin care preparations; cellulose for the food industry; cellulose derivatives for use manufacturing; diagnostic preparations and substances for scientific purposes; diagnostic testing materials for scientific use; none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen
Class 3
Cosmetics and cosmetic preparations; cosmetic-based cellulose fleececellulose foilscellulose filmscellulose fibrescellulose fibre suspensions and cellulose gels impregnated with cosmetic active ingredientsparticularly skin care preparations; beauty masks; skin masks; facial masks; body masksskin care preparations; none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen.
Class 5
Medical and veterinary preparationscellulose productsbiosynthetic cellulose and synthetic cellulose for skin treatment; flat cellulosecellulose filmscellulose foilscellulose fleececellulose fibrescellulose fibre suspension and cellulose gels for medicalveterinary and pharmaceutical purposes; pharmaceutical preparations featuring cellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspensions and cellulose gels for use in the treatment of skin; pharmaceutical preparations featuring cellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspension and cellulose gels impregnated with pharmaceutical agents for use in the treatment of skin; pads impregnated with medicated preparation for use in the treatment of skin for medical purposes; cellulose for pharmaceuticalveterinary and medical purposes; pharmaceutical preparations for skin care; absorbent sanitary pads for skin treatment; pantyliners; diapers; sanitary pads; preparations for the treatment of burnsexcept ready-to-use wound dressings; diagnostic preparations for pharmaceuticalmedical and veterinary purposes.
Class 17
Semi-finished productssynthetic resins for making materials for dressing wounds and surgical dressings; semi-finished productsacrylics made of cellulosecellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspension and cellulose gels for making material for dressings and surgical dressings; semi-finished molded products of cellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspension and cellulose gels for use as semi-finished products for making absorbent sanitary articlespantylinersdiapers and sanitary pads; semi-processed cellulose fleececellulose foilcellulose films and cellulose fibres for use in food and beverages
Publications
History of USPTO decisions and trademark events.
29 publications found
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/02/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/15/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/15/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/17/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/16/2025
GNRT
NON-FINAL ACTION E-MAILED
12/16/2025
CNRT
NON-FINAL ACTION WRITTEN
12/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/26/2025
RFNT
REFUSAL PROCESSED BY IB
07/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/13/2025
RFRR
REFUSAL PROCESSED BY MPU
06/13/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/29/2025
CNRT
NON-FINAL ACTION WRITTEN
03/28/2025
DOCK
ASSIGNED TO EXAMINER
03/27/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/16/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/16/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/16/2025
Continuous trademark protection
Get notified about every new filing that threatens BIOCELLIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.